Testing Theory-Enhanced Messaging to Promote COVID-19 Vaccination: Results from a Randomized Controlled Trial

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Uptake of the COVID-19 vaccine has been low in the US (~ 22% among adults in 2023 − 24 1 ) despite ongoing public health recommendations. This has been linked to many factors including pandemic fatigue, reduced risk perception, dis/misinformation, and recently, symptoms of depression and anxiety. Novel communication and messaging strategies are one potential approach to promote vaccine uptake. This randomized control trial tests two communication-based approaches compared to standard public health messaging on vaccine uptake in a cohort of adult US residents. We completed a 3-arm, parallel-group, assessor-blinded stratified-randomized trial between April-15-2024 and May-2-2024. Eligible individuals were ≥ 18 years old who: 1)had received at least one dose of the COVID-19 vaccine, but, 2)had not received COVID-19 vaccine doses since September-11-2023, and 3)had not been infected with SARS-CoV-2 in the past three months. We purposively sampled eligible individuals with and without symptoms of anxiety and depression. Participants were randomly allocated to: 1) attitudinal inoculation intervention; 2) CBT-kernels intervention; or 3) standard public health messaging intervention. At four-week follow up, these groups showed no meaningful differences in uptake (CBT- kernels:1.6% [95%CI:0.4–2.8]; Inoculation:0.9% [95%CI:0.0-1.8]; and Standard:1.3% [95%CI:0.3–2.4]) or level of vaccine willingness. Successful efforts to increase uptake of the COVID-19 vaccine via theory-enhanced messaging remain elusive.

Article activity feed